Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.1Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-1.6
Enterprise Value $M-2.5EPS (TTM) $-1.6Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.910-y EBITDA Growth Rate %--Quick Ratio8.5Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %18.6Current Ratio8.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-84.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-95.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M19.2ROIC % (ttm)-1,920,579.3Gross Margin Increase y-yN

Gurus Latest Trades with ONCS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ONCS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONCS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DHILLON PUNITPresident and CEO 2016-07-31Buy3,000$1.44-11.11view
Mohan-Peterson SheelaCL&CO 2016-07-31Buy3,000$1.44-11.11view
DHILLON AVTAR SDirector 2015-10-16Buy10,000$4.36-70.64view
Mohan-Peterson SheelaChief Legal Officer 2015-10-16Buy520$4.24-69.81view
DHILLON PUNITPresident and CEO 2015-10-16Buy10,000$4.25-69.88view
SLANSKY RICHARD BCFO 2015-07-06Buy150,000$6.12-79.08view
DHILLON PUNITPresident and CEO 2015-06-10Buy2,500$6.74-81.01view
MAIDA ANTHONY E IIIDirector 2014-03-20Buy1,140$16.2-92.1view
DHILLON PUNITPresident and CEO 2014-03-19Buy2,500$16-92view

Press Releases about ONCS :

Quarterly/Annual Reports about ONCS:

News about ONCS:

Articles On GuruFocus.com

More From Other Websites
OncoSec to Present at the 9th Annual LD Micro Main Event Dec 01 2016
OncoSec Announces Key Corporate Initiatives at Inaugural Investor & Analyst Day on November 17, 2016 Nov 17 2016
OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2016 Nov 15 2016
OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2016 Nov 15 2016
OncoSec Presents Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC)... Nov 11 2016
OncoSec Announces Positive Interim Response Data at the Society for Immunotherapy of Cancer (SITC)... Nov 08 2016
OncoSec to Present at Scientific and Investment Conferences and to Host Inaugural Investor and... Nov 01 2016
OncoSec Rallies 13% on Huge Volumes (ONCS) Oct 28 2016
ONCOSEC MEDICAL INC Financials Oct 19 2016
OncoSec to Host Investor & Analyst Day on November 17, 2016 Spotlighting Industry-Leading... Oct 18 2016
OncoSec to Host Investor & Analyst Day on November 17, 2016 Spotlighting Industry-Leading... Oct 18 2016
Maxim Group Says OncoSec Still a “Buy” (ONCS) Oct 17 2016
Maxim Group Says OncoSec Still a “Buy” (ONCS) Oct 17 2016
OncoSec Announces Fourth Quarter and Year End Results for Fiscal Year 2016 Oct 13 2016
ONCOSEC MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 13 2016
OncoSec Announces Fourth Quarter and Year End Results for Fiscal Year 2016 Oct 13 2016
OncoSec Announces Acceptance of Late Breaking Abstract at Upcoming Society for Immunotherapy of... Oct 13 2016
OncoSec to Present at Scientific and Investment Conferences in October Oct 10 2016
OncoSec Sets Fourth-Quarter Conference Call (ONCS) Oct 03 2016
OncoSec to Host Fourth Quarter and Fiscal Year End Financial Results Conference Call on October 13,... Sep 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)